Hostname: page-component-7b7567c8c-2jgqx Total loading time: 0 Render date: 2026-11-19T15:34:05.194Z Has data issue: false hasContentIssue false

Toward a Biochemical Classification of Depressive Disorders IX

DST Results and Platelet MAO Activity

Published online by Cambridge University Press:  29 January 2018

Alan F. Schatzberg*
Affiliation:
Affective Disease Program, McLean Hospital, Belmont, MA 02178
Anthony J. Rothschild
Affiliation:
Harvard Medical School and Affective Disease Program, McLean Hospital
Benjamin Gerson
Affiliation:
Harvard Medical School; Psychiatric Chemistry Laboratory, New England Deaconess Hospital
Jan E. Lerbinger
Affiliation:
Affective Disease Program, McLean Hospital
Joseph J. Schildkraut
Affiliation:
Harvard Medical School; Neuropsychopharmocology Laboratory, Massachusetts Mental Health Center; and Psychiatric Chemistry Laboratory, New England Deaconess Hospital
*
∗ Correspondence
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Post-dexamethasone cortisol and platelet monoamine oxidase (MAO) activity levels were examined in 50 depressed patients. The incidence of non-suppression was significantly greater in patients with high platelet MAO activity than in those with low activity. Similar results were obtained when males and females were analysed separately. The mean 4 p.m. post-dexamethasone cortisol level was significantly higher in those patients who had high MAO activity than in their low MAO counterparts. Moreover, a statistically significant positive correlation was observed between platelet MAO activity and 4 p.m. post-dexamethasone cortisol levels.

Information

Type
Research Article
Copyright
Copyright © 1985 The Royal College of Psychiatrists 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.